EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Functional genomics screens reveal a role for TBC1D24 and SV2B in antibody-dependent enhancement of dengue virus infection

Laura Belmont iD, Maya Contreras, Catiana H Cartwright-Acar iD, Caleb D Marceau, Aditi Agrawal, Lisa M Levoir, Jay Lubow, Leslie Goo iD

Journal of Virology · 2024

DOI: 10.1128/jvi.01582-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Laura Belmont und 7 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Dengue Virus, Dengue, GTPase-Activating Proteins, Antibodies, Viral. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Under some conditions, dengue virus (DENV) can hijack IgG antibodies to facilitate its uptake into target cells expressing Fc gamma receptors (FcgR)—a process known as antibody-dependent enhancement (ADE) of infection. Beyond a requirement for FcgR, host dependency factors for this unusual IgG-mediated infection route remain unknown. To identify cellular factors exclusively required for ADE, here, we performed CRISPR knockout (KO) screens in an in vitro system poorly permissive to infection in the absence of IgG antibodies. Validating our approach, a top hit was FcgRIIa, which facilitates the binding and internalization of IgG-bound DENV but is not required for canonical infection. Additionally, we identified host factors with no previously described role in DENV infection, including TBC1D24 and SV2B, which have known functions in regulated secretion. Using genetic knockout and trans -complemented cells, we validated a functional requirement for these host factors in ADE assays performed with monoclonal antibodies and polyclonal sera in multiple cell lines and using all four DENV serotypes. We show that knockout of TBC1D24 or SV2B impaired the binding of IgG-DENV complexes to cells without affecting FcgRIIa expression levels. Thus, we identify cellular factors beyond FcgR that promote efficient ADE of DENV infection. Our findings represent a first step toward advancing fundamental knowledge behind the biology of a non-canonical infection route implicated in disease. IMPORTANCE Antibodies can paradoxically enhance rather than inhibit dengue virus (DENV) infection in some cases. To advance knowledge of the functional requirements of antibody-dependent enhancement (ADE) of infection beyond existing descriptive studies, we performed a genome-scale CRISPR knockout (KO) screen in an optimized in vitro system permissive to efficient DENV infection only in the presence of IgG. In addition to FcgRIIa, a known receptor that facilitates IgG-mediated uptake of IgG-bound, but not naked DENV particles, our screens identified TBC1D24 and SV2B, cellular factors with no known role in DENV infection. We validated a functional role for TBC1D24 and SV2B in mediating ADE of all four DENV serotypes in different cell lines and using various antibodies. Thus, we identify cellular factors beyond Fc gamma receptors that promote ADE mechanisms. This study represents a first step toward advancing fundamental knowledge beyond a poorly understood non-canonical viral entry mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dengue VirusDengueGTPase-Activating ProteinsAntibodies, ViralImmunoglobulin GHumansReceptors, IgGCell LineGenomicsGene Knockout TechniquesAnimalsHost-Pathogen InteractionsVirus InternalizationHEK293 Cells

Stichwörter der Autor:innen

CRISPRantibody-dependent enhancement of infectiondengue virus

Substanzen

GTPase-Activating ProteinsAntibodies, ViralImmunoglobulin GReceptors, IgG

Autor:innen und Institutionen

  • Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, Washington, USA.
  • Chan Zuckerberg Biohub, San Francisco, California, USA.

ORCID-Profile: Laura Belmont, Catiana H Cartwright-Acar, Leslie Goo

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • NIH HHS
  • Hypothesis Fund
  • Viral Pathogenesis and Evolution Training Grant
  • Fred Hutchinson Cancer Center Diverse Trainee Fund
  • Chan Zuckerberg Biohub - San Francisco
  • Disease of Public Health Importance Training Grant

Zitieren

APA

Belmont, L., Contreras, M., Cartwright-Acar, C. H., Marceau, C. D., Agrawal, A., Levoir, L. M., Lubow, J., & Goo, L. (2024). Functional genomics screens reveal a role for TBC1D24 and SV2B in antibody-dependent enhancement of dengue virus infection. Journal of Virology. https://doi.org/10.1128/jvi.01582-24

Vancouver

Belmont L, Contreras M, Cartwright-Acar CH, Marceau CD, Agrawal A, Levoir LM, et al. Functional genomics screens reveal a role for TBC1D24 and SV2B in antibody-dependent enhancement of dengue virus infection. Journal of Virology. 2024. doi:10.1128/jvi.01582-24

BibTeX
@article{Belmont2024,
  author = {Belmont, Laura and Contreras, Maya and Cartwright-Acar, Catiana H and Marceau, Caleb D and Agrawal, Aditi and Levoir, Lisa M and Lubow, Jay and Goo, Leslie},
  title = {Functional genomics screens reveal a role for TBC1D24 and SV2B in antibody-dependent enhancement of dengue virus infection},
  journal = {Journal of Virology},
  year = {2024},
  doi = {10.1128/jvi.01582-24}
}
Kostenlos starten →